Gambia Cough Syrup Deaths
-
{
- All
- News
-
India Inspects Drug Factories As Gambia Controversy Lingers
The government has begun inspecting some drug factories across the country, the health ministry said on Tuesday, as it tries to ensure high standards after an Indian company's cough and cold syrups were linked to deaths in Gambia.
-
Cough Syrups Linked To Gambia Child Deaths Found To Be Of Standard Quality: Centre
Cough syrup samples of Maiden Pharmaceuticals have been found to be of standard quality, the government has told Parliament.
-
Cough Syrup Deaths In Gambia Hits A Key Growth Area For India
Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.
-
WHO Chief Scientist Says Deaths Due To Indian Cough Syrup In Gambia "Serious Issue"
Chief scientist at the World Health Organization (WHO) Dr Soumya Swaminathan on Thursday said the death of children in Gambia, potentially linked to four Indian-made cough syrups, was a serious issue.
-
Indonesia Bans Cough Syrup Material Linked To Gambia Child Deaths
Indonesia on Saturday banned ingredients linked to the deaths of 70 children in Gambia from cough syrups in the Southeast Asian country as it investigates acute kidney damage that has killed more than 20 children in the capital Jakarta this year.
-
India Inspects Drug Factories As Gambia Controversy Lingers
The government has begun inspecting some drug factories across the country, the health ministry said on Tuesday, as it tries to ensure high standards after an Indian company's cough and cold syrups were linked to deaths in Gambia.
-
Cough Syrups Linked To Gambia Child Deaths Found To Be Of Standard Quality: Centre
Cough syrup samples of Maiden Pharmaceuticals have been found to be of standard quality, the government has told Parliament.
-
Cough Syrup Deaths In Gambia Hits A Key Growth Area For India
Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.
-
WHO Chief Scientist Says Deaths Due To Indian Cough Syrup In Gambia "Serious Issue"
Chief scientist at the World Health Organization (WHO) Dr Soumya Swaminathan on Thursday said the death of children in Gambia, potentially linked to four Indian-made cough syrups, was a serious issue.
-
Indonesia Bans Cough Syrup Material Linked To Gambia Child Deaths
Indonesia on Saturday banned ingredients linked to the deaths of 70 children in Gambia from cough syrups in the Southeast Asian country as it investigates acute kidney damage that has killed more than 20 children in the capital Jakarta this year.
